Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 2;17(12):4846-4856.
doi: 10.1080/21645515.2021.1985354. Epub 2021 Oct 7.

The landscape of COVID-19 vaccination among healthcare workers at the first round of COVID-19 vaccination in China: willingness, acceptance and self-reported adverse effects

Xinxin Ye  1 , Wan Ye  2 , Jinyue Yu  3 , Yuzhen Gao  4 , Ziyang Ren  1 , Lanzhen Chen  5 , Ao Dong  6 , Qian Yi  1 , Chenju Zhan  7 , Yanni Lin  8 , Yangxin Wang  9 , Simin Huang  10 , Peige Song  1
Affiliations

The landscape of COVID-19 vaccination among healthcare workers at the first round of COVID-19 vaccination in China: willingness, acceptance and self-reported adverse effects

Xinxin Ye et al. Hum Vaccin Immunother. .

Abstract

The COVID-19 vaccines have been developed in a wide range of countries. This study aimed to examine factors that related to vaccination rates and willingness to be vaccinated against COVID-19 among Chinese healthcare workers (HCWs). From 3rd February to 18th February, 2021, an online cross-sectional survey was conducted among HCWs to investigate factors associated with the acceptance and willingness of COVID-19 vaccination. Sociodemographic characteristics and the acceptance of COVID-19 vaccination among Chinese HCWs were evaluated. A total of 2156 HCWs from 21 provinces in China responded to this survey (effective rate: 98.99%)), among whom 1433 (66.5%) were vaccinated with at least one dose. Higher vaccination rates were associated with older age, working as a clinician, having no personal religion, working in a fever clinic or higher hospital grade, and having received vaccine education, family history for influenza vaccination and strong familiarity with the vaccine. Willingness for vaccination was related to working in midwestern China, considerable knowledge of the vaccine, received vaccine education, and strong confidence in the vaccine. Results of this study can provide evidence for the government to improve vaccine coverage by addressing vaccine hesitancy in the COVID-19 pandemic and future public health emergencies.

Keywords: COVID-19; cross-sectional studies; healthcare workers; online survey; public health; vaccine.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
The study framework.
Figure 2.
Figure 2.
MHLC psychology results for the participants.
Figure 3.
Figure 3.
Factors analysis for willingness to receive the vaccine(a) and the COVID-19 vaccination (b).
Figure 4.
Figure 4.
The subjective factors for the participants.
Figure 5.
Figure 5.
Adverse events from COVID-19 vaccination.
See this image and copyright information in PMC

References

    1. Koff WC, Schenkelberg T, Williams T, Baric RS, McDermott A, Cameron CM, Cameron MJ, Friemann MB, Neumann G, Kawaoka Y, et al. Development and deployment of COVID-19 vaccines for those most vulnerable. Sci Transl Med. 2021;13:eabd1525. doi:10.1126/scitranslmed.abd1525. - DOI - PubMed
    1. Bloom BR, Nowak GJ, Orenstein W.. “When will we have a vaccine?” - understanding questions and answers about COVID-19 vaccination. N Engl J Med. 2020;383:2202–04. doi:10.1056/NEJMp2025331. - DOI - PubMed
    1. Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, Stoop J, Tete S, Van Damme W, Leroux-Roels I, et al. Interim results of a phase 1-2a trial of Ad26.COV2.S COVID-19 vaccine. N Engl J Med. 2021;384:1824–35. doi:10.1056/NEJMoa2034201. - DOI - PMC - PubMed
    1. Corbett KS, Flynn B, Foulds KE, Francica JR, Boyoglu-Barnum S, Werner AP, Flach B, O’Connell S, Bock KW, Minai M, et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in Nonhuman primates. N Engl J Med. 2020;383:1544–55. doi:10.1056/NEJMoa2024671. - DOI - PMC - PubMed
    1. Murphy J, Vallieres F, Bentall RP, Shevlin M, McBride O, Hartman TK, McKay R, Bennett K, Mason L, Gibson-Miller J, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12:29. doi:10.1038/s41467-020-20226-9. - DOI - PMC - PubMed

Substances